which advanced stage nonsmall cell lung cancer patients attain long-term survival?
GROUND: The core strategy of American College of Chest Physicians lung cancer guidelines is identification of the earliest symptoms of lung cancer and the immediate initiation of diagnosis and treatment. In the absence of screening, most symptomatic lung cancer is discovered at advanced stages, with the goal of long-term survival entirely dependent on effective treatment of stage III and IV lung cancer. METHODS: In a retrospective review, all patients diagnosed with stage IIIA, IIIB, and IV nonsmall cell lung cancer (NSCLC) between the years 1986 and 2001 at City of Hope National Medical Center who survived 5 years or longer were analyzed to identify parameters that might predict long-term survival. RESULTS: Of 846 patients presenting with stage III or IV disease, 56 (6.6%) survived 5 years or longer. Sixteen patients died of primary tumor progression beyond 5 years. Two 5-year survivors died of second tobacco-caused neoplasms, and 16 died from medical conditions potentially related to
Related Questions
- Does Granulocyte Colony-Stimulating Factor Affect Survival in Patients with Advanced Non-small Cell Lung Cancer?
- Do gender and race influence survival in patients with non-small cell lung cancer brain metastases?
- Which patients with stage III non-small cell lung cancer should undergo surgical resection?
